Lundbeck to Acquire Longboard Pharmaceuticals to Expand its Neuroscience Pipeline
Under the terms of the agreement, Lundbeck will commence a tender offer for all outstanding shares of Longboard common stock, whereby Longboard shareholders will be offered a payment of USD 60.00 per share in cash.
Neuroscience | 15/10/2024 | By Aishwarya
Evotec Announces Progress in its Collaboration with Bristol Myers Squibb
Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases where there remains a significant unmet medical need for therapies that slow down or reverse disease progression.
Neuroscience | 12/08/2024 | By Aishwarya | 190
AbbVie Completes Acquisition of Cerevel Therapeutics
AbbVie has announced the completion of its acquisition of Cerevel Therapeutics.
Neuroscience | 02/08/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy